BioLineRx (BLRX) Net Income (2011 - 2026)

BioLineRx's Net Income history runs 14 years deep, the most recent figure standing at -$2.2 million for Q4 2025.

• In Q4 2025, Net Income rose 29.84% year-over-year to -$2.2 million; the TTM figure through Dec 2025 stood at -$2.0 million (up 78.03% YoY), while the FY2025 annual figure was -$2.0 million, up 78.03% from the prior year.
• Net Income for Q4 2025 stood at -$2.2 million, down from -$977000.0 in the prior quarter.
• The five-year high for Net Income was $5.1 million in Q1 2025, with the low at -$39.8 million in Q3 2021.
• The 5-year median for Net Income is -$5.8 million (2022), against an average of -$6.9 million.
• The sharpest annual moves came in 2021 and 2025: Net Income tumbled 823.49% in 2021, then surged 836.64% in 2025.
• BioLineRx's Net Income stood at -$4.3 million in 2021, then slumped by 33.16% to -$5.7 million in 2022, then sank by 142.26% to -$13.9 million in 2023, then soared by 77.05% to -$3.2 million in 2024, then advanced by 29.84% to -$2.2 million in 2025.
• Business Quant data shows BLRX's Net Income at -$2.2 million in Q4 2025, -$977000.0 in Q3 2025, and -$3.9 million in Q2 2025.